Vaccine Confidence

Investing in Ontario’s Vaccine Research

At Merck, we have a shared belief that collaborations are critical to keeping Canadians informed and healthy. With this idea in mind, we are proud to announce our partnership, including a $3 million investment, with the University of Toronto’s Centre for Vaccine Preventable Diseases, the Dalla Lana School of Public Health, and the Government of Ontario.

This partnership will bring forward new approaches for conveying the importance of vaccines as a cornerstone of public health and create an important tool in the prevention and control of infectious diseases in Canada and internationally, ultimately helping save lives. Read the University of Toronto's announcement here.

“The COVID-19 pandemic has shone a light on the critical importance of immunization and innovative collaborations. As a science-based company with a long-standing legacy in vaccines, we are honoured to be partnering with the Dalla Lana School of Public Health, the University of Toronto’s Centre for Vaccine Preventable Diseases and the Government of Ontario. We are confident that this invaluable collaboration will help strengthen Ontario’s standing as a world-leading home to scientific innovation.”

AnnA Van Acker,

President and Managing Director

The Hope of Vaccines

Vaccines are one of the greatest achievements in public health to help reduce transmission and achieve population immunity, ultimately helping save and improving lives.

Today, we know that improving health outcomes of our communities can have a positive impact on economic and societal well-being, for example, through longer working lives, higher productivity, improved educational outcomes, social inclusion, and reduced healthcare costs.1

As a key player in the life science industry, we have a responsibility to understand the reasons why some people or communities2 are hesitant towards vaccines and to ensure that they are making decisions about their health informed by knowledge and by science. The hope vaccines bring is too precious for us not to do so.

We have been part of the realization of that hope with the discovery, development, and delivery of effective vaccines.

The other side of the coin is the threat that diseases which have already been eradicated, or at least greatly minimized through immunization, could come back to posing a risk to individual and public health.3

We can’t let that happen.

References

1 The Economic Value of Vaccination: Why Prevention Is Wealth. J Mark Access Health Policy. 2015;3.

2 Quinn SC, Andrasik MP. Addressing Vaccine Hesitancy in BIPOC Communities — Toward Trustworthiness, Partnership, and Reciprocity. N Engl J Med. Published online March 31, 2021:NEJMp2103104.

3 Gardner L, Dong E, Khan K, Sarkar S. Persistence of US Measles Risk Due to Vaccine Hesitancy and Outbreaks Abroad. Lancet Infect Dis. 2020;20(10):1114-1115.